Table 4 Statistical comparison between results obtained by the proposed methods and the reported method for the determination of TCB and LVM in Eradex Forte® suspension
Parameters | TCB | LVM | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reported Methoda [8] | D0 (304 nm) | D0 (220 nm) | D1 (310 nm) | D1 (P 228–216 nm) | DD1 (P230-220nm) | CV | CNV | Reported Methoda [8] | D0 (214 nm) | D1 (P221 nm) | DD1 (P219 nm) | |||||||||
RS-SS | RS-SS | CM-SS | FC-SS | DS-SS | DS-SS | D1 CM-SS | D1 FC-SS | Â | Â | Â | RS-SS | CM-SS | FC-SS | DS-SS | D1 CM-SS | D1 FC-SS | Â | |||
Mean | 99.89 | 99.97 | 100.19 | 100.19 | 100.26 | 100.55 | 100.53 | 100.44 | 100.49 | 98.97 | 99.09 | 99.78 | 100.48 | 100.25 | 99.39 | 100.01 | 100.62 | 99.37 | 99.45 | 102.09 |
S.D | 0.59 | 0.59 | 1.98 | 1.99 | 1.53 | 1.99 | 1.99 | 2.05 | 2.04 | 0.62 | 1.21 | 1.32 | 0.76 | 0.76 | 1.74 | 1.53 | 1.95 | 2.07 | 1.77 | 0.58 |
n | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Variance | 0.35 | 0.348 | 3.92 | 3.98 | 3.06 | 3.98 | 3.98 | 4.20 | 4.08 | 0.38 | 1.47 | 2.64 | 0.58 | 0.58 | 3.03 | 2.34 | 3.80 | 4.28 | 3.54 | 1.16 |
F (19) | … | 5.828 (19) | 11.297 (19) | 11.45 (19) | 6.74 (19) | 11.49 (19) | 11.42 (19) | 12.04 (19) | 11.92 (19) | 1.12 (19) | 4.24 (19) | 5.02 (19) | … | 6.75 (19) | 5.28 (19) | 4.12 (19) | 6.64 (19) | 7.47 (19) | 5.51 (19) | 1.71 (19) |
Students tb (2.776) | … | 1.211 (2.776) | 1.092 (2.776) | 1.08 (2.776) | 1.45 (2.776) | 1.38 (2.776) | 1.37 (2.776) | 1.26 (2.776) | 1.31 (2.776) | 0.16 (2.776) | 0.26 (2.776) | 1.06 (2.776) | … | 0.19 (2.776) | 0.99 (2.776) | 0.48 (2.776) | 0.11 (2.776) | 0.87 (2.776) | 0.92 (2.776) | 2.94 (2.776) |